Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Reimport Options Being Weighed By Jeffords After Defeat In House, HHS

Executive Summary

Sen. Jeffords (I-Vt.) is weighing options for how to address prescription drug reimportation in the Senate following rejection of reimportation by the House and HHS.

You may also be interested in...



Rx Importation Sinks In Senate, But Leaves Anticounterfeiting Regs In Its Wake

Although the drug importation provisions included in the Senate's version of the FDA Revitalization Act are not expected to create a cross-border trading system, their anticounterfeiting language could still have a significant impact on industry

Rx Importation Sinks In Senate, But Leaves Anticounterfeiting Regs In Its Wake

Although the drug importation provisions included in the Senate's version of the FDA Revitalization Act are not expected to create a cross-border trading system, their anticounterfeiting language could still have a significant impact on industry

Rx Imports: House Cmte. Tells FDA To Consider “Counterfeit-Proof” Packages

Reimportation advocates want FDA to consider "counterfeit-proof" drug packaging technologies that could enable U.S. consumers to safely import prescriptions from Canada

Related Content

UsernamePublicRestriction

Register

PS038193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel